Related Experiment Video
Updated: Jun 13, 2025
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Intracellular bactericidal activity and action mechanism of MDP1 antimicrobial peptide against VRSA and MRSA in human
Shirin Dashtbin1,2, Shabnam Razavi1,2, Mokhtar Ganjali Koli3,4
1Microbial Biotechnology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Introduction:
Staphylococcus aureus is a prominent cause of postoperative infections, often persisting within host cells, leading to chronic infections. Conventional antibiotics struggle to eliminate intracellular S. aureus due to poor cell penetration. Antimicrobial peptides are a new hope for tackling intracellular bacteria. Accordingly, this study examines the antimicrobial peptide MDP1, derived from melittin, for its efficacy against intracellular S. aureus.
Methods:
In this study, the physiochemical properties (Prediction of three-dimensional structure, circular dichroism and helical wheel projection analysis) were investigated. Extracellular antibacterial activity and cytotoxicity of MDP1 were also assessed. The mechanism of interaction of MDP1 with S. aureus was evaluated by molecular dynamic simulation, atomic force and confocal microscopy. Bacterial internalization into an endothelial cell model was confirmed through culture and transmission electron microscopy. The effect of the peptide on intracellular bacteria was investigated by culture and epi-fluorescence microscopy.
Results And Discussion:
3D structural prediction proved the conformation of MDP1 as an α-helix peptide. Helical-wheel projection analysis indicated the proper orientation of hydrophobic amino acid residues for membrane interaction. CD spectroscopy of MDP1 showed that MDP1 in SDS 10 and 30 mM adopted 87 and 91% helical conformation. Atomic force and confocal microscopy assessments as well as molecular dynamics studies revealed the peptide-bacterial membrane interaction. MDP1, at the concentration of 0.32 μg mL-1, demonstrated a fold reduction of 21.7 ± 1.8, 1.7 ± 0.2, and 7.3 ± 0.8 in intracellular bacterial load for ATCC, VRSA, and MRSA, respectively. Molecular dynamics results demonstrate a preferential interaction of MDP1 with POPG/POPE membranes, primarily driven by electrostatic forces and hydrogen bonding. In POPC systems, two out of four MDP1 interacted effectively, while all four MDP1 engaged with POPG/POPE membranes. Gathering all data together, MDP1 is efficacious in the reduction of intracellular VRSA and MRSA proved by culture and epi-fluorescent microscopy although further studies should be performed to increase the intracellular activity of MDP1.
Insights
The antimicrobial peptide MDP1 effectively reduces intracellular Staphylococcus aureus, including antibiotic-resistant strains like VRSA and MRSA. This offers a promising new strategy against persistent bacterial infections.
Area of Science:
- Microbiology
- Biochemistry
- Drug Discovery
Background:
- Staphylococcus aureus is a major cause of postoperative infections, frequently residing within host cells and leading to chronic conditions.
- Conventional antibiotics have limited efficacy against intracellular S. aureus due to poor penetration into host cells.
- Antimicrobial peptides (AMPs) represent a potential therapeutic avenue for combating intracellular bacterial infections.
Purpose of the Study:
- To investigate the efficacy of the melittin-derived antimicrobial peptide MDP1 against intracellular Staphylococcus aureus.
- To characterize the physiochemical properties and mechanism of action of MDP1.
Main Methods:
- Physiochemical characterization including 3D structure prediction, circular dichroism, and helical wheel analysis.
- Assessment of extracellular antibacterial activity and cytotoxicity.
- Evaluation of MDP1's interaction with S. aureus using molecular dynamics, atomic force, and confocal microscopy.
- Confirmation of bacterial internalization and assessment of intracellular bacterial load using microscopy and culture techniques.
Main Results:
- MDP1 was confirmed as an alpha-helical peptide with properties conducive to membrane interaction.
- MDP1 demonstrated significant reduction in intracellular bacterial load for Vancomycin-Resistant S. aureus (VRSA) and Methicillin-Resistant S. aureus (MRSA).
- Molecular dynamics simulations revealed preferential interaction of MDP1 with specific membrane lipid compositions, driven by electrostatic forces and hydrogen bonding.
Conclusions:
- MDP1 shows significant efficacy in reducing intracellular VRSA and MRSA, indicating its potential as a therapeutic agent.
- The peptide's mechanism involves direct interaction with bacterial membranes.
- Further research is warranted to enhance the intracellular activity of MDP1 for broader clinical application.
